Can a simple RNA test predict pancreatic cancer outcomes?

NCT ID NCT04765410

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study examined small RNA molecules called microRNAs in tissue samples from 57 people with pancreatic cancer. The samples were collected during a routine endoscopic ultrasound procedure. Researchers aimed to see if certain microRNA patterns are linked to how aggressive the cancer is, how long patients live, and how they respond to treatment. The goal is to eventually use this information to personalize care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • "Carol Davila" University Central Emergency Hospital

    Bucharest, Sector 1, 010825, Romania

  • "Prof Dr Agrippa Ionescu" Emergency Hospital

    Bucharest, Sector 1, 011356, Romania

  • "Victor Babes" National Pathology Institute

    Bucharest, Sector, 050096, Romania

  • Clinical Emergency Hospital Bucharest

    Bucharest, Sector 1, 014461, Romania

  • Fundeni Clinical Institute

    Bucharest, Sector 2, 022328, Romania